Abstract |
A series of 9-anilinoacridine derivatives substituted in the anilino ring with a variety of phosphoramide and related substitutents has been prepared, and the antitumor activity has been evaluated both in vivo and in vitro against the L1210 or P-388 mouse leukemia systems. The DNA-binding properties were measured using the ethidium displacement method, and the structural requirements for strong binding were found to differ from those for antileukemic activity. For high biological activity a marked preference for oxygen-containing substituents on the phosphorus atom was noted, while for high DNA binding a requirement for nitrogen-containing or cyclized substituents was observed. The most active congeners, as assayed in both in vitro and in vivo systems, were comparable in activity to the clinically utilized anilinoacridine derivative N-[4'-(9-acridinylamino)-3'-methoxyphenyl] methanesulfonamide ( m-AMSA, amsacrine).
|
Authors | G W Rewcastle, B C Baguley, B F Cain |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 25
Issue 10
Pg. 1231-5
(Oct 1982)
ISSN: 0022-2623 [Print] United States |
PMID | 7143362
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Aminoacridines
- Antineoplastic Agents
- DNA
|
Topics |
- Aminoacridines
(chemical synthesis, metabolism, pharmacology)
- Animals
- Antineoplastic Agents
(chemical synthesis)
- Chemical Phenomena
- Chemistry
- DNA
(metabolism)
- Leukemia L1210
(drug therapy)
- Leukemia P388
(drug therapy)
- Mice
- Mice, Inbred C57BL
- Mice, Inbred DBA
|